Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters











Database
Language
Publication year range
1.
Ter Arkh ; 93(11): 1306-1315, 2021 Nov 15.
Article in Russian | MEDLINE | ID: mdl-36286653

ABSTRACT

AIM: An analysis of coronavirus infection in Russia and evaluation of different AVT regimens effectiveness. MATERIALS AND METHODS: The study involved a retrospective analysis of 1082 patient records with laboratory-confirmed COVID-19 in 17 regions of Russia. The number of men and women was equal, mean age 48.718.1 (median 50). Patients with moderate COVID-19 (85%) versus mild COVID-19 (15%) were characterized by higher age (median 54 vs 21 years; p0.001), higher body mass index (27.8 vs 23.4; p0.001), prevalence of chronic diseases (75.3% vs 8.5%; p0.001), including circulatory system diseases (37.8%). Moderate COVID-19 characterized higher intoxication (10.86.1 vs 4.22.7 days; p0.001) and catarrhal symptoms duration (10.25.4 vs 6.14.1 days; p0.001). RESULTS: During hospitalization 92% of the patients received AVT, 77% antibiotics, and 16% corticosteroids. Umifenovir therapy resulted in a significant reduction of intoxication (8.75.5 vs 11.75.5 days; p0.001) and catarrhal symptoms duration (8.85.1 vs 12.04.9 days; p0.001) compared to the group without AVT. The usage of INF reduced intoxication symptoms compared with the group without AVT (8.97.5 vs 11.75.5; p0.05). Therapy with hydroxychloroquine, imidazolylethanamide pentandioic acid, and lopinavir + ritonavir combination did not affect the course of COVID-19. Most of adverse reactions were related to antibiotics. CONCLUSION: Umifenovir therapy and inclusion of interferon in AVT regimens was associated improvement in the clinical manifestation of the disease among patients.


Subject(s)
COVID-19 , Male , Humans , Female , Middle Aged , Young Adult , Adult , Lopinavir/therapeutic use , COVID-19/epidemiology , Ritonavir/therapeutic use , Hydroxychloroquine/therapeutic use , SARS-CoV-2 , Retrospective Studies , Antiviral Agents/therapeutic use , Interferons , Anti-Bacterial Agents/therapeutic use
2.
Urologiia ; (5): 91-94, 2017 Oct.
Article in Russian | MEDLINE | ID: mdl-29135150

ABSTRACT

This is a case report of an elderly patient with urogenital tuberculosis and concurrent tuberculosis of peripheral inguinal lymph nodes. The disease manifested by a fistulous form of inguinal lymphadenitis for 10 years and spread to the kidneys and genitals, but the patient did not seek medical attention. Changes on the glans penis prompted him to consult dermatovenereologist. Due to ineffective treatment and uncovering the scar in the inguinal area the patient was send to an anti-tuberculosis institution, where he was diagnosed with tuberculosis involving the kidneys, prostate, epididymis, penis, inguinal lymph nodes. The patient had a history of a contact with the patient with respiratory tuberculosis. Treatment with antituberculosis drugs produced a positive effect.


Subject(s)
Antitubercular Agents/administration & dosage , Tuberculosis, Male Genital/drug therapy , Tuberculosis, Male Genital/pathology , Tuberculosis, Renal/drug therapy , Tuberculosis, Renal/pathology , Chronic Disease , Humans , Kidney/pathology , Male , Middle Aged , Penis/pathology , Prostate/pathology
3.
Article in Russian | MEDLINE | ID: mdl-27228669

ABSTRACT

AIM: Analyze main epidemiologic indicators for HIV-infection on the territory of SFR for the period from 2012 to 2014 with allotment of contributions of regions into the epidemic for development of personalized regional program for further containment of HIV spread. MATERIALS AND METHODS: Data of main statistical forms and monthly reports of all the regions situated on the territory of the district were used. RESULTS: At large, on both the studied territory and some regions a tendency of growth of HIV-infection morbidity with predominant parenteral transmission was detected. HIV-infection continues to be detected most frequently in young able-bodied population. The number of patients detected for the first time at AIDS stage increases annually, and an increase of lethality among HIV-infected was noted. CONCLUSION: Prognostic data for the next year are indicated.


Subject(s)
Epidemics , HIV Infections/epidemiology , HIV Infections/virology , HIV-1/pathogenicity , Humans , Siberia
4.
Zh Mikrobiol Epidemiol Immunobiol ; (6): 108-116, 2016 11.
Article in Russian | MEDLINE | ID: mdl-30695397

ABSTRACT

The review is dedicated to features of clinical manifestations of infections caused by Epstein- Barr virus (EBV) in HIV-infected patients, problems of diagnostics and execution of antiviral therapy in the case of combination of these infections. Individuals at AIDS stage develop tumors, associated with EBV: non-Hodgkin's lymphomas, including Berkitt's,lymphoma, primary B-cell lymphoma,of CNS, nasopharyngeal carcinoma. Formation of lymphoid interstitial pneumonitis and leukoplakia is known to be associated with EBV. A large list of preparations that are inhibitors of EBV replication are currently known, however, there is no clear pathogenetically justified therapy scheme for patients with this infection against the background of HIV-infection.


Subject(s)
Coinfection , Epstein-Barr Virus Infections , HIV Infections , HIV-1/immunology , Herpesvirus 4, Human/immunology , Burkitt Lymphoma/drug therapy , Burkitt Lymphoma/immunology , Burkitt Lymphoma/pathology , Burkitt Lymphoma/virology , Coinfection/drug therapy , Coinfection/immunology , Coinfection/pathology , Epstein-Barr Virus Infections/drug therapy , Epstein-Barr Virus Infections/immunology , Epstein-Barr Virus Infections/pathology , HIV Infections/drug therapy , HIV Infections/immunology , HIV Infections/pathology , Humans , Leukoplakia/drug therapy , Leukoplakia/immunology , Leukoplakia/pathology , Leukoplakia/virology , Lung Diseases, Interstitial/drug therapy , Lung Diseases, Interstitial/immunology , Lung Diseases, Interstitial/pathology , Lung Diseases, Interstitial/virology , Lymphoma, AIDS-Related/drug therapy , Lymphoma, AIDS-Related/immunology , Lymphoma, AIDS-Related/pathology , Lymphoma, AIDS-Related/virology , Nasopharyngeal Carcinoma/drug therapy , Nasopharyngeal Carcinoma/immunology , Nasopharyngeal Carcinoma/virology , Nasopharyngeal Neoplasms/drug therapy , Nasopharyngeal Neoplasms/immunology , Nasopharyngeal Neoplasms/pathology , Nasopharyngeal Neoplasms/virology
5.
Vestn Oftalmol ; 132(3): 103-107, 2016.
Article in Russian | MEDLINE | ID: mdl-28635829

ABSTRACT

Ocular tuberculosis (OTB) is a specific infectious (bacterial) disease dealt with by ophthalmologists and phthisiatricians. This is a serious illness with chronic, persistent course and extremely doubtful prognosis. Chemotherapy, even if effective, can still be followed by a decrease in visual acuity. Clinical recovery is often unstable. Ocular tuberculosis is largely associated with permanent disability and, as a result, a decline in quality of life of these patients. Statistical reporting does not always reflect the true prevalence of the disease as it sometimes develops in patients with pre-existing specific pulmonary involvement. This article discusses all pathogenetic mechanisms of OTB that have been described so far. Attention is paid to modern diagnostic methods, including spectral optical coherence tomography. Positive results of endonasal electrophoresis for the treatment of OTB are described.


Subject(s)
Antitubercular Agents/therapeutic use , Quality of Life , Tuberculosis, Ocular , Humans , Prognosis , Treatment Outcome , Tuberculosis, Ocular/diagnosis , Tuberculosis, Ocular/drug therapy , Tuberculosis, Ocular/physiopathology , Tuberculosis, Ocular/psychology , Visual Acuity
6.
Ter Arkh ; 87(11): 46-50, 2015.
Article in Russian | MEDLINE | ID: mdl-26821416

ABSTRACT

AIM: To identify predictors for the poor outcome of infiltrative pulmonary tuberculosis (IPTB). SUBJECTS AND METHODS: The social, epidemiological, and medical risk factors and clinical features of IPTB were assessed in 130 first detected patients. The findings were classified using a cluster analysis and then a variance analysis, followed by the ranking of its results. RESULTS: The primarily diagnosed disseminated destructive process with respiratory and cardiopulmonary failure, excretion of both resistant and multi-resistant pathogenic bacteria had a strong impact on the poor outcome of tuberculosis (TB) in the first detected patients. Its outcome was also influenced by a set of social factors, such as poor material living conditions, stay in corrective labor facilities, and a lack of education. The unfavorable outcome of TB was significantly due to organizational factors, such as bad habits; refusal to undergo fluorography during a few years; and a medical factor as comorbidities. CONCLUSION: Based on the identified factors, the authors formulated recommendations for working with the first detected IPTB patients at risk for a poor disease outcome.


Subject(s)
Tuberculosis, Pulmonary/diagnosis , Adult , Female , Humans , Male , Middle Aged , Prognosis , Risk Factors , Russia/epidemiology , Socioeconomic Factors , Tuberculosis, Pulmonary/complications , Tuberculosis, Pulmonary/epidemiology
SELECTION OF CITATIONS
SEARCH DETAIL